Stock listing

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Selected listing: 1276N · BIVA · MXN · MX

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (BIVA:1276N), Health Technology. Latest release Oct 8, 2026: Jiangsu Hengrui Pharmaceuticals : Hengrui…

1276N:BIVAMXNMXUpdated October 2, 2026

Ticker: BIVA:1276/N
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BIVA
Currency: MXN

Latest news from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Jiangsu Hengrui Pharmaceuticals : Hengrui Pharma Announces EMA Validation of Marketing Authorisation Application for Wevdury (fuzuloparib) in Combination with Abiraterone for Metastatic Castration-Resistant Prostate Cancer

October 8, 2026

Jiangsu Hengrui Pharmaceuticals : Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596

September 29, 2026

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

September 24, 2026

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of the Company's A-Shares

September 17, 2026

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Notice on Convening the 1st Extraordinary General Meeting in 2026

September 8, 2026

All Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news →

Research Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A company profile

View the public company page for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A on 6ix.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news

Read company news and market updates connected to Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A investor events

Find investor webinars, events, and replay context for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A.